Release Date: 09/09/11 12:53 Summary: GGB: End of Offer - ASX Listing Rule 3.4.1 Disclosure Price Sensitive: No Download Document 54.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%